Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Harm Reduct J. 2012 Jan 1;9:1. doi: 10.1186/1477-7517-9-1.

Prescribing cannabis for harm reduction.

Author information

  • PainExhibit,com, 9008 El Cajon Way, #4, Sacramento, CA, 95826, USA. Mark@PainExhibit.com.

Abstract

Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.

PMID:
22208773
[PubMed]
PMCID:
PMC3295721
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk